Home>Clinical research>Clinical trials by disease>A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176

How to use the speech recognition tool?

NCT02544217

A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176

A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2015-05-01
  • Closing Date: 2015-09-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Neuro-Ophthalmology Rare Diseases (WG2)

Subscribe

* indicates required

This ERN is supported by: